- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2090-2441
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
COVID-19 susceptibility: potential of ACE2 polymorphisms ; volume:21 ; number:1 ; day:21 ; month:9 ; year:2020 ; pages:1-8 ; date:12.2020
The Egyptian journal of medical human genetics ; 21, Heft 1 (21.9.2020), 1-8, 12.2020
- Creator
-
Chaudhary, Mayank
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s43042-020-00099-9
- URN
-
urn:nbn:de:101:1-2020110723213115759938
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chaudhary, Mayank
- SpringerLink (Online service)
Other Objects (12)
ACE2 polymorphisms impact COVID-19 severity in obese patients
Association of ACE2 and TMPRSS2 towards COVID-19 susceptibility
Association of ACE2 polymorphisms with susceptibility to essential hypertension and dyslipidemia in Xinjiang, China
New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis
ACE2‐Variants Indicate Potential SARS‐CoV‐2‐Susceptibility in Animals: A Molecular Dynamics Study
Polymorphisms and mutations of ACE2 and TMPRSS2 genes are associated with COVID-19: a systematic review
Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population
Angiotensin-converting enzyme 2 (ACE2) polymorphisms and susceptibility of severe SARS-CoV-2 in a subset of Pakistani population
Genetic association of ACE2 and TMPRSS2 polymorphisms with COVID-19 severity; a single centre study from Egypt
Comparative ACE2 variation and primate COVID-19 risk
ACE2, a drug target for COVID-19 treatment?
ACE2 polymorphisms impact COVID-19 severity in obese patients
Association of ACE2 and TMPRSS2 towards COVID-19 susceptibility
Association of ACE2 polymorphisms with susceptibility to essential hypertension and dyslipidemia in Xinjiang, China
New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis
ACE2‐Variants Indicate Potential SARS‐CoV‐2‐Susceptibility in Animals: A Molecular Dynamics Study
Polymorphisms and mutations of ACE2 and TMPRSS2 genes are associated with COVID-19: a systematic review
Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population
Angiotensin-converting enzyme 2 (ACE2) polymorphisms and susceptibility of severe SARS-CoV-2 in a subset of Pakistani population
Genetic association of ACE2 and TMPRSS2 polymorphisms with COVID-19 severity; a single centre study from Egypt
Comparative ACE2 variation and primate COVID-19 risk
ACE2, a drug target for COVID-19 treatment?
ACE2 polymorphisms impact COVID-19 severity in obese patients
Association of ACE2 and TMPRSS2 towards COVID-19 susceptibility
Association of ACE2 polymorphisms with susceptibility to essential hypertension and dyslipidemia in Xinjiang, China
New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis
ACE2‐Variants Indicate Potential SARS‐CoV‐2‐Susceptibility in Animals: A Molecular Dynamics Study
Polymorphisms and mutations of ACE2 and TMPRSS2 genes are associated with COVID-19: a systematic review
Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population
Angiotensin-converting enzyme 2 (ACE2) polymorphisms and susceptibility of severe SARS-CoV-2 in a subset of Pakistani population
Genetic association of ACE2 and TMPRSS2 polymorphisms with COVID-19 severity; a single centre study from Egypt
Comparative ACE2 variation and primate COVID-19 risk